These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep; 1999 Dec 17; 48(RR-14):1-9. PubMed ID: 10632443 [Abstract] [Full Text] [Related]
3. Neuraminidase inhibitors: zanamivir and oseltamivir. McNicholl IR, McNicholl JJ. Ann Pharmacother; 2001 Jan 17; 35(1):57-70. PubMed ID: 11197587 [Abstract] [Full Text] [Related]
4. [Neuraminidase inhibitors in therapy of influenza]. Fladerer P, Wenisch C. Acta Med Austriaca; 2000 Jan 17; 27(5):133-40. PubMed ID: 11261262 [Abstract] [Full Text] [Related]
5. [Neuraminidase inhibitor]. Kaji M. Nihon Rinsho; 2000 Nov 17; 58(11):2293-8. PubMed ID: 11225320 [Abstract] [Full Text] [Related]
6. Updated treatment for influenza A and B. Montalto NJ, Gum KD, Ashley JV. Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232 [Abstract] [Full Text] [Related]
7. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb 01; 15(81):21-30. PubMed ID: 16548114 [Abstract] [Full Text] [Related]
8. [Anti-virals for influenza virus infection]. Sugaya N. Uirusu; 2005 Jun 01; 55(1):111-4. PubMed ID: 16308537 [Abstract] [Full Text] [Related]
9. Neuraminidase inhibitors for influenza. Moscona A. N Engl J Med; 2005 Sep 29; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
10. Neuraminidase inhibitors for preventing and treating influenza in children. Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Cochrane Database Syst Rev; 2003 Sep 29; (3):CD002744. PubMed ID: 12917931 [Abstract] [Full Text] [Related]
11. Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza. Dreitlein WB, Maratos J, Brocavich J. Clin Ther; 2001 Mar 29; 23(3):327-55. PubMed ID: 11318072 [Abstract] [Full Text] [Related]
12. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]. Kaji M. Nihon Rinsho; 2003 Nov 29; 61(11):1975-9. PubMed ID: 14619441 [Abstract] [Full Text] [Related]
13. Neuraminidase inhibitors and relief of influenza symptoms. Lemon M, Meade F. S D J Med; 2000 Mar 29; 53(3):99-100. PubMed ID: 10745653 [No Abstract] [Full Text] [Related]
14. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]. de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD. Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):73-9. PubMed ID: 14753128 [Abstract] [Full Text] [Related]
15. Neuraminidase inhibitors in patients with underlying airways disease. Williamson JC, Pegram PS. Am J Respir Med; 2002 Jan 10; 1(2):85-90. PubMed ID: 14720062 [Abstract] [Full Text] [Related]
16. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K. N Engl J Med; 1997 Sep 25; 337(13):874-80. PubMed ID: 9302301 [Abstract] [Full Text] [Related]
17. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Vogel GE. Med Microbiol Immunol; 2002 Dec 25; 191(3-4):161-3. PubMed ID: 12458352 [Abstract] [Full Text] [Related]
18. [Influenza]. Sugaya N. Nihon Rinsho; 2003 Feb 25; 61 Suppl 2():135-40. PubMed ID: 12722202 [No Abstract] [Full Text] [Related]
19. Oseltamivir resistance in influenza A (H5N1) infection. Gupta RK, Nguyen-Van-Tam JS. N Engl J Med; 2006 Mar 30; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890 [No Abstract] [Full Text] [Related]
20. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Commun Dis Intell Q Rep; 2003 Mar 30; 27(4):542-7. PubMed ID: 15508516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]